Global Human Rabies Immunoglobulin (IM) Market Insights, Forecast to 2025

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017. For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU. Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%. China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.

The global Human Rabies Immunoglobulin (IM) market is valued at 290 million US$ in 2018 and will reach 510 million US$ by the end of 2025, growing at a CAGR of 7.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Rabies Immunoglobulin (IM) market based on company, product type, end user and key regions.

This report studies the global market size of Human Rabies Immunoglobulin (IM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Rabies Immunoglobulin (IM) in these regions.

This research report categorizes the global Human Rabies Immunoglobulin (IM) market by top players/brands, region, type and end user. This report also studies the global Human Rabies Immunoglobulin (IM) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    CSL Behring

    Grifols

    Sanofi

    Sichuan Yuanda Shuyang

    CNBG

    Kamada

    CBPO

    Shuanglin Bio

    Weiguang Bio

    Shanghai RAAS

    Bharat Serum

    VINS

    ERIG

    HRIG

    Category II Exposure

    Category III Exposure

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

    To study and analyze the global Human Rabies Immunoglobulin (IM) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

    To understand the structure of Human Rabies Immunoglobulin (IM) market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Human Rabies Immunoglobulin (IM) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

    To project the value and sales volume of Human Rabies Immunoglobulin (IM) submarkets, with respect to key regions.

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    History Year: 2014-2018

    Base Year: 2018

    Estimated Year: 2019

    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Rabies Immunoglobulin (IM) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

    1.1 Human Rabies Immunoglobulin (IM) Product

    1.2 Market Segments

    1.3 Key Manufacturers Covered

    1.4 Market by Type

        1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Product

        1.4.2 ERIG

        1.4.3 HRIG

    1.5 Market by End User

        1.5.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by End User

        1.5.2 Category II Exposure

        1.5.3 Category III Exposure

    1.6 Study Objectives

    1.7 Years Considered

2 Executive Summary

    2.1 Global Human Rabies Immunoglobulin (IM) Market Size

        2.1.1 Global Human Rabies Immunoglobulin (IM) Revenue 2014-2025

        2.1.2 Global Human Rabies Immunoglobulin (IM) Sales 2014-2025

    2.2 Human Rabies Immunoglobulin (IM) Growth Rate by Regions

        2.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Regions

        2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Regions

3 Breakdown Data by Manufacturers

    3.1 Human Rabies Immunoglobulin (IM) Sales by Manufacturers

        3.1.1 Human Rabies Immunoglobulin (IM) Sales by Manufacturers

        3.1.2 Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers

        3.1.3 Global Human Rabies Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI)

    3.2 Human Rabies Immunoglobulin (IM) Revenue by Manufacturers

        3.2.1 Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2014-2019)

        3.2.2 Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2014-2019)

    3.3 Human Rabies Immunoglobulin (IM) Price by Manufacturers

    3.4 Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Product Types

        3.4.1 Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters

        3.4.2 Manufacturers Human Rabies Immunoglobulin (IM) Product Type

        3.4.3 Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market

    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

    4.1 Global Human Rabies Immunoglobulin (IM) Sales by Product

    4.2 Global Human Rabies Immunoglobulin (IM) Revenue by Product

    4.3 Human Rabies Immunoglobulin (IM) Price by Product

5 Breakdown Data by End User

    5.1 Overview

    5.2 Global Human Rabies Immunoglobulin (IM) Breakdown Data by End User

6 North America

    6.1 North America Human Rabies Immunoglobulin (IM) by Countries

        6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Countries

        6.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Countries

        6.1.3 United States

        6.1.4 Canada

        6.1.5 Mexico

    6.2 North America Human Rabies Immunoglobulin (IM) by Product

    6.3 North America Human Rabies Immunoglobulin (IM) by End User

7 Europe

    7.1 Europe Human Rabies Immunoglobulin (IM) by Countries

        7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Countries

        7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Countries

        7.1.3 Germany

        7.1.4 France

        7.1.5 UK

        7.1.6 Italy

        7.1.7 Russia

    7.2 Europe Human Rabies Immunoglobulin (IM) by Product

    7.3 Europe Human Rabies Immunoglobulin (IM) by End User

8 Asia Pacific

    8.1 Asia Pacific Human Rabies Immunoglobulin (IM) by Countries

        8.1.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Countries

        8.1.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Countries

        8.1.3 China

        8.1.4 Japan

        8.1.5 Korea

        8.1.6 India

        8.1.7 Australia

        8.1.8 Indonesia

        8.1.9 Malaysia

        8.1.10 Philippines

        8.1.11 Thailand

        8.1.12 Vietnam

        8.1.13 Singapore

    8.2 Asia Pacific Human Rabies Immunoglobulin (IM) by Product

    8.3 Asia Pacific Human Rabies Immunoglobulin (IM) by End User

9 Central & South America

    9.1 Central & South America Human Rabies Immunoglobulin (IM) by Countries

        9.1.1 Central & South America Human Rabies Immunoglobulin (IM) Sales by Countries

        9.1.2 Central & South America Human Rabies Immunoglobulin (IM) Revenue by Countries

        9.1.3 Brazil

    9.2 Central & South America Human Rabies Immunoglobulin (IM) by Product

    9.3 Central & South America Human Rabies Immunoglobulin (IM) by End User

10 Middle East and Africa

    10.1 Middle East and Africa Human Rabies Immunoglobulin (IM) by Countries

        10.1.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Countries

        10.1.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Countries

        10.1.3 GCC Countries

        10.1.4 Turkey

        10.1.5 Egypt

        10.1.6 South Africa

    10.2 Middle East and Africa Human Rabies Immunoglobulin (IM) by Product

    10.3 Middle East and Africa Human Rabies Immunoglobulin (IM) by End User

11 Company Profiles

    11.1 CSL Behring

        11.1.1 CSL Behring Company Details

        11.1.2 Company Business Overview

        11.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered

        11.1.5 CSL Behring Recent Development

    11.2 Grifols

        11.2.1 Grifols Company Details

        11.2.2 Company Business Overview

        11.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.2.4 Grifols Human Rabies Immunoglobulin (IM) Products Offered

        11.2.5 Grifols Recent Development

    11.3 Sanofi

        11.3.1 Sanofi Company Details

        11.3.2 Company Business Overview

        11.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.3.4 Sanofi Human Rabies Immunoglobulin (IM) Products Offered

        11.3.5 Sanofi Recent Development

    11.4 Sichuan Yuanda Shuyang

        11.4.1 Sichuan Yuanda Shuyang Company Details

        11.4.2 Company Business Overview

        11.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered

        11.4.5 Sichuan Yuanda Shuyang Recent Development

    11.5 CNBG

        11.5.1 CNBG Company Details

        11.5.2 Company Business Overview

        11.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.5.4 CNBG Human Rabies Immunoglobulin (IM) Products Offered

        11.5.5 CNBG Recent Development

    11.6 Kamada

        11.6.1 Kamada Company Details

        11.6.2 Company Business Overview

        11.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.6.4 Kamada Human Rabies Immunoglobulin (IM) Products Offered

        11.6.5 Kamada Recent Development

    11.7 CBPO

        11.7.1 CBPO Company Details

        11.7.2 Company Business Overview

        11.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.7.4 CBPO Human Rabies Immunoglobulin (IM) Products Offered

        11.7.5 CBPO Recent Development

    11.8 Shuanglin Bio

        11.8.1 Shuanglin Bio Company Details

        11.8.2 Company Business Overview

        11.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered

        11.8.5 Shuanglin Bio Recent Development

    11.9 Weiguang Bio

        11.9.1 Weiguang Bio Company Details

        11.9.2 Company Business Overview

        11.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered

        11.9.5 Weiguang Bio Recent Development

    11.10 Shanghai RAAS

        11.10.1 Shanghai RAAS Company Details

        11.10.2 Company Business Overview

        11.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2014-2019)

        11.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered

        11.10.5 Shanghai RAAS Recent Development

    11.11 Bharat Serum

    11.12 VINS

12 Future Forecast

    12.1 Human Rabies Immunoglobulin (IM) Market Forecast by Regions

        12.1.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Regions 2019-2025

        12.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Regions 2019-2025

    12.2 Human Rabies Immunoglobulin (IM) Market Forecast by Product

        12.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Product 2019-2025

        12.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Product 2019-2025

    12.3 Human Rabies Immunoglobulin (IM) Market Forecast by End User

    12.4 North America Human Rabies Immunoglobulin (IM) Forecast

    12.5 Europe Human Rabies Immunoglobulin (IM) Forecast

    12.6 Asia Pacific Human Rabies Immunoglobulin (IM) Forecast

    12.7 Central & South America Human Rabies Immunoglobulin (IM) Forecast

    12.8 Middle East and Africa Human Rabies Immunoglobulin (IM) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    13.1 Market Opportunities and Drivers

    13.2 Market Challenges

    13.3 Market Risks/Restraints

    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

    14.1 Value Chain Analysis

    14.2 Human Rabies Immunoglobulin (IM) Customers

    14.3 Sales Channels Analysis

        14.3.1 Sales Channels

        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

    16.1 Research Methodology

        16.1.1 Methodology/Research Approach

        16.1.2 Data Source

    16.2 Author Details

    16.3 Disclaimer

List of Tables and Figures

    Figure Human Rabies Immunoglobulin (IM) Product Picture

    Table Human Rabies Immunoglobulin (IM) Market Segments

    Table Key Manufacturers Human Rabies Immunoglobulin (IM) Covered

    Table Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)

    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Product 2014-2025

    Figure ERIG Product Picture

    Table Major Manufacturers of ERIG

    Figure HRIG Product Picture

    Table Major Manufacturers of HRIG

    Table Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by End User 2019-2025 (K Units)

    Figure Category II Exposure

    Figure Category III Exposure

    Figure Human Rabies Immunoglobulin (IM) Report Years Considered

    Figure Global Human Rabies Immunoglobulin (IM) Market Size 2014-2025 (Million US$)

    Figure Global Human Rabies Immunoglobulin (IM) Sales 2014-2025 (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Market Size by Regions 2014-2019 (K Units) & (Million US$)

    Table Global Human Rabies Immunoglobulin (IM) Sales by Regions 2014-2019 (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions 2014-2019

    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions 2014-2019

    Figure 2018 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions

    Table Global Human Rabies Immunoglobulin (IM) Revenue by Regions 2014-2019 (Million US$)

    Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions 2014-2019

    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions 2014-2019

    Figure 2018 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions

    Table Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2014-2019) (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers (2014-2019)

    Figure Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers in 2018

    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2014-2019) (Million USD)

    Table Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2014-2019)

    Figure Human Rabies Immunoglobulin (IM) Value Share by Manufacturers in 2018

    Table Key Manufacturers Human Rabies Immunoglobulin (IM) Price (2014-2019) (USD/Unit)

    Table Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution and Headquarters

    Table Manufacturers Human Rabies Immunoglobulin (IM) Product Type

    Table Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market

    Table Manufacturers Mergers & Acquisitions, Expansion Plans

    Table Global Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Share by Product (2014-2019)

    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Product in 2018

    Table Global Human Rabies Immunoglobulin (IM) Revenue by Product (2014-2019) (Million US$)

    Table Global Human Rabies Immunoglobulin (IM) Revenue Share by Product (2014-2019)

    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Product (2014-2019)

    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Product in 2018

    Table Human Rabies Immunoglobulin (IM) Price by Product 2014-2019 (USD/Unit)

    Table Global Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Share by End User (2014-2019)

    Figure Global Sales Human Rabies Immunoglobulin (IM) Market Share by End User (2014-2019)

    Figure Global Sales Human Rabies Immunoglobulin (IM) Market Share by End User in 2018

    Figure North America Human Rabies Immunoglobulin (IM) Sales Growth Rate 2014-2019 (K Units)

    Figure North America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2014-2019 (Million US$)

    Table North America Human Rabies Immunoglobulin (IM) Sales by Countries (2014-2019) (K Units)

    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2014-2019)

    Figure 2018 North America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries

    Table North America Human Rabies Immunoglobulin (IM) Revenue by Countries (2014-2019) (Million US$)

    Table North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2014-2019)

    Figure 2018 North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries

    Figure United States Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure United States Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (K Units)

    Figure Canada Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Mexico Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Table North America Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure 2018 North America Human Rabies Immunoglobulin (IM) Market Share by Product

    Table North America Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by End User (2014-2019)

    Figure 2018 North America Human Rabies Immunoglobulin (IM) Market Share by End User

    Figure Europe Human Rabies Immunoglobulin (IM) Sales Growth Rate 2014-2019 (K Units)

    Figure Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2014-2019 (Million US$)

    Table Europe Human Rabies Immunoglobulin (IM) Sales by Countries (2014-2019) (K Units)

    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2014-2019)

    Figure 2018 Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Countries

    Table Europe Human Rabies Immunoglobulin (IM) Revenue by Countries (2014-2019) (Million US$)

    Table Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2014-2019)

    Figure 2018 Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries

    Figure Germany Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure France Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure UK Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure UK Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Italy Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Russia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Table Europe Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure 2018 Europe Human Rabies Immunoglobulin (IM) Market Share by Product

    Table Europe Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by End User (2014-2019)

    Figure 2018 Europe Human Rabies Immunoglobulin (IM) Market Share by End User

    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Sales Growth Rate 2014-2019 (K Units)

    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2014-2019 (Million US$)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Countries (2014-2019) (K Units)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2014-2019)

    Figure 2018 Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Countries

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Countries (2014-2019) (Million US$)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2014-2019)

    Figure 2018 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries

    Figure China Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Japan Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Korea Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure India Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Australia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Indonesia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Indonesia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Malaysia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Malaysia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Philippines Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Philippines Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Thailand Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Thailand Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Vietnam Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Vietnam Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Singapore Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Singapore Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure 2018 Asia Pacific Human Rabies Immunoglobulin (IM) Market Share by Product

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by End User (2014-2019)

    Figure 2018 Asia Pacific Human Rabies Immunoglobulin (IM) Market Share by End User

    Figure Central & South America Human Rabies Immunoglobulin (IM) Sales Growth Rate 2014-2019 (K Units)

    Figure Central & South America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2014-2019 (Million US$)

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Countries (2014-2019) (K Units)

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2014-2019)

    Figure 2018 Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries

    Table Central & South America Human Rabies Immunoglobulin (IM) Revenue by Countries (2014-2019) (Million US$)

    Table Central & South America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2014-2019)

    Figure 2018 Central & South America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries

    Figure Brazil Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Argentina Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure 2018 Central & South America Human Rabies Immunoglobulin (IM) Market Share by Product

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by End User (2014-2019)

    Figure 2018 Central & South America Human Rabies Immunoglobulin (IM) Market Share by End User

    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Growth Rate 2014-2019 (K Units)

    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2014-2019 (Million US$)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Countries (2014-2019) (K Units)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2014-2019)

    Figure 2018 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Countries

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Countries (2014-2019) (Million US$)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2014-2019)

    Figure 2018 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries

    Figure GCC Countries Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure GCC Countries Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Turkey Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Turkey Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure Egypt Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure Egypt Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Figure South Africa Human Rabies Immunoglobulin (IM) Sales Growth Rate (2014-2019) (K Units)

    Figure South Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2014-2019) (Million US$)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Product (2014-2019) (K Units)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Product (2014-2019)

    Figure 2018 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Share by Product

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by End User (2014-2019) (K Units)

    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by End User (2014-2019)

    Figure 2018 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Share by End User

    Table CSL Behring Company Details

    Table CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table CSL Behring Recent Development

    Table Grifols Company Details

    Table Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Grifols Recent Development

    Table Sanofi Company Details

    Table Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Sanofi Recent Development

    Table Sichuan Yuanda Shuyang Company Details

    Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Sichuan Yuanda Shuyang Recent Development

    Table CNBG Company Details

    Table CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table CNBG Recent Development

    Table Kamada Company Details

    Table Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Kamada Recent Development

    Table CBPO Company Details

    Table CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table CBPO Recent Development

    Table Shuanglin Bio Company Details

    Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Shuanglin Bio Recent Development

    Table Weiguang Bio Company Details

    Table Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Weiguang Bio Recent Development

    Table Shanghai RAAS Company Details

    Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)

    Table Shanghai RAAS Recent Development

    Table Bharat Serum Company Details

    Table VINS Company Details

    Table Global Human Rabies Immunoglobulin (IM) Sales Forecast by Regions 2019-2025 (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Regions 2019-2025

    Table Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Regions 2019-2025 (Million US$)

    Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Regions 2019-2025

    Table Global Human Rabies Immunoglobulin (IM) Sales Forecast by Product 2019-2025 (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Product 2019-2025

    Table Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Product 2019-2025 (Million US$)

    Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Product 2019-2025

    Table Global Human Rabies Immunoglobulin (IM) Sales Forecast by End User 2019-2025 (K Units)

    Table Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by End User 2019-2025

    Figure North America Human Rabies Immunoglobulin (IM) Sales Growth Rate Forecast (2019-2025) (K Units)

    Figure North America Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2019-2025) (Million US$)

    Figure Europe Human Rabies Immunoglobulin (IM) Sales Growth Rate Forecast (2019-2025) (K Units)

    Figure Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2019-2025) (Million US$)

    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Sales Growth Rate Forecast (2019-2025) (K Units)

    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2019-2025) (Million US$)

    Figure Central & South America Human Rabies Immunoglobulin (IM) Sales Growth Rate Forecast (2019-2025) (K Units)

    Figure Central & South America Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2019-2025) (Million US$)

    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Growth Rate Forecast (2019-2025) (K Units)

    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2019-2025) (Million US$)

    Table Human Rabies Immunoglobulin (IM) Value Chain

    Table Human Rabies Immunoglobulin (IM) Customers List

    Table Human Rabies Immunoglobulin (IM) Distributors List

    Table Research Programs/Design for This Report

    Figure Bottom-up and Top-down Approaches for This Report

    Figure Data Triangulation

    Table Key Data Information from Secondary Sources

    Table Key Data Information from Primary Sources